NYSE - Nasdaq Real Time Price
USD
CVS Health Corporation (CVS)
90.80
+0.85
(+0.94%)
As of 11:36:49 AM EDT. Market Open.
Trade CVS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Truist Securities
66/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/12/2026
Analyst
Leerink Partners
Rating Action
Maintains
Rating
Outperform
Price Action
Lowers
Price Target
119 -> 112
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Truist Securities
|
66 | 68 | 100 | Buy
|
118 | 2026-07-15 |
|
Piper Sandler
|
65 | 67 | 99 | Overweight
|
99 | 2026-03-31 |
|
JP Morgan
|
61 | 67 | 100 | Overweight
|
118 | 2026-08-12 |
|
Evercore ISI Group
|
58 | 54 | 100 | Outperform
|
125 | 2026-08-06 |
|
Barclays
|
58 | 59 | 100 | Overweight
|
108 | 2026-08-07 |
|
Morgan Stanley
|
55 | 54 | 96 | Overweight
|
111 | 2026-06-04 |
|
Mizuho
|
54 | 57 | 100 | Outperform
|
115 | 2026-06-08 |
|
RBC Capital
|
50 | 48 | 86 | Outperform
|
113 | 2026-07-09 |
|
B of A Securities
|
50 | 46 | 99 | Buy
|
110 | 2026-06-24 |
|
UBS
|
49 | 45 | 89 | Buy
|
118 | 2026-09-03 |
Rows per page
1-10 of 15
Upgrades & Downgrades
| Maintains | Leerink Partners: Outperform to Outperform | 10/12/2026 |
| Maintains | UBS: Buy to Buy | 9/3/2026 |
| Maintains | Argus Research: Buy to Buy | 8/19/2026 |
| Maintains | JP Morgan: Overweight to Overweight | 8/12/2026 |
| Maintains | UBS: Buy to Buy | 8/6/2026 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 8/6/2026 |
